A novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinoma

Primary bladder adenocarcinoma (PBA) is an epithelial malignancy with pure glandular differentiation, without evidence of typical urothelial (transitional cell) carcinoma. PBA is rare, accounting for 0.

5%-2% of all malignant bladder neoplasms, and it is seen more frequently in men than in women and is commonly diagnosed in the sixth decade of life.¹⁻³ Clinical presentation includes hematuria and symptoms of bladder irritation.² PBA is common in schistosomiasis-endemic regions and among patients with congenital bladder exstrophy (ectopia vesicae); it mostly arises in the trigone and posterior bladder wall.⁴ In contrast, urachal adenocarcinomas arise within urachal remnants (residual tissues from the embryonic allantoic stalk connecting the umbilicus and bladder), close to the dome and anterior wall of the bladder. Morphologically, PBA is classifed into enteric and nonenteric types, which includes mucinous, signetring cell variant, clear-cell type, hepatoid, and mixed forms.² Currently, there is no standard of care in the management of PBA. We present the case of a patient with metastatic PBA with intestinal differentiation and wild-type KRAS, who was treated with colorectal cancer regimens.

The Journal of community and supportive oncology. 2016 Feb [Epub]

Venkata K Pokuri, Norbert Sule, Caroline Perfetto, Michael Duff, Christopher Kopp, Khurshid Guru, Dhiren Shah, Saby George

Department of Medical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA. Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York, USA., Department of Medicine, State University of New York, Buffalo, New York, USA., Department of Radiation Oncology, Cancer Care of Western New York, Buffalo, New York, USA., Department of Urology, Western New York Urology Associates, Buffalo, New York, USA., Department of Urologic Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA., Department of Radiation Oncology, Cancer Care of Western New York, Buffalo, New York, USA., Department of Medical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe